Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Natural cytotoxicity receptors (NCRs) are a family of activating receptors expressed primarily on natural killer (NK) cells, including NKp30, NKp44, NKp46, and NKp80, that trigger NK cell cytotoxicity and cytokine secretion (e.g., IFNγ) against tumor cells, virus-infected cells, and pathogens via ITAM-containing adapters like DAP12 and signaling through Syk/Zap70 kinases. They recognize diverse ligands such as B7-H6, heparan sulfate proteoglycans, and pathogen-derived molecules, with splice variants enabling activating or inhibitory functions depending on context, and play key roles in tumor surveillance, viral control, and immune regulation in tissues like decidua.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Natural cytotoxicity receptors (NCRs).